share_log

HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Lowers Price Target to $36

Benzinga ·  Feb 20 07:47

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price target from $38 to $36.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment